Welcome to our dedicated page for Know Labs SEC filings (Ticker: USBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Know Labs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Know Labs's regulatory disclosures and financial reporting.
Amendment No. 1 to Schedule 13D reports that Robert Gregory Kidd and Goldeneye 1995 LLC hold an aggregate of 357,815,000 shares of USBC, Inc. common stock, representing approximately 92.1% of the 388,143,679 shares outstanding as of September 15, 2025. The filing states Mr. Kidd and Goldeneye each have sole voting and dispositive power over these shares. On September 19, 2025 the parties entered into a Registration Rights Agreement and the issuer filed a Form S-1 covering resale of the shares issued to Goldeneye in the private placement. No other transactions in the prior 60 days were reported.
USBC, Inc. discloses portions of its definitive proxy statement including director background, related-party professional fees and governance procedures. The filing states that Mr. Cronin holds multiple engineering degrees and a B.A. in Psychology from the University of Vermont. The company reports it paid ipCG approximately $390,000 for the year ended September 30, 2024 and $713,000 for the year ended September 30, 2023 in professional fees. It also states Mr. Cronin is not considered an independent director because of prior service as Interim Chief Technology Officer from September 2024 to August 2025. The document includes placeholders for compensation components such as base salary, stock options, benefits and accrued vacation pay and restates proxy submission requirements for shareholder proposals.
FAQ
What is the current stock price of Know Labs (USBC)?
What is the market cap of Know Labs (USBC)?
